Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcifediol in chronic haemodialysis patients with vitamin D deficiency
2011-004984-55Phase 3Terminated
- Sponsor
- Italian Society of Nephrology
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of calcifediol in Vitamin D deficiency (VDD), secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) (2 arms), sponsored by Italian Society of Nephrology. Primary endpoint: Combined end point of fatal or non fatal myocardial infarction, fatal or non fatal stroke, sudden death, death for other causes (not traumatic). Started Mar 2012; status: terminated.
02
Drugs
calcifediol
03
Conditions
Vitamin D deficiency (VDD)secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-004984-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004984-55.